Evidence on the chronic care model in the new millennium. Health Aff (Millwood). 2009;28:75 85. KEY WORDS: AHA Scientific Statements acute coronary syndrome angina, unstable antiplatelet agents coronary artery bypass graft electrocardiography ischemia myocardial infarction percutaneous coronary intervention troponin Appendix 1. Author Relationships With Industry and Other Entities (Relevant) 2014 AHA/ACC Guideline for the Management of Patients With Non-St-Elevation Acute Coronary Syndromes Committee Member Employment Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* Ezra A. Amsterdam (Chair) University of California (Davis) Medical Center, Division of Cardiology Professor None None None None None None None Nanette K. Wenger (Vice Chair) Emory University, School of Medicine Professor of Medicine (Cardiology) Abbott Amgen AstraZeneca Gilead Sciences Janssen Pharmaceuticals Medtronic Merck Pfizer None None Abbott Eli Lilly Gilead Sciences Merck Pfizer None None All sections and 8. Ralph G. Brindis University of California, San Francisco Department of Medicine and the Phillip R. Lee Institute for Health Policy Studies Clinical Professor of Medicine None Volcano None None None None None Donald E. Casey, Jr Atlantic Health Vice President of Health and Chief Medical Officer None None None None None None None Theodore G. Ganiats University of California, San Diego School of Medicine Executive Director of Health Services Research Center None None None None None None None David R. Holmes, Jr Mayo Clinic Consultant, Cardiovascular Diseases None None None None None None None Allan S. Jaffe Mayo Clinic, Cardiovascular Division Professor of Medicine Abbott Alere Amgen Beckman- Coulter Critical Diagnostics ET Healthcare Ortho Clinical Diagnostic Radiometer Roche Thermo-Fishert Trinity None None None None None All sections 7.6, and 8. 